's stock had its "buy" rating restated by analysts at Oppenheimer in a research note issued to investors on Tuesday. A number of other research firms have also recently commented on JNPR.
↧
's stock had its "buy" rating restated by analysts at Oppenheimer in a research note issued to investors on Tuesday. A number of other research firms have also recently commented on JNPR.